This invention relates to pharmacologically-active novel compounds comprising β-fluoromethylene-5-hydroxytryptophan and derivatives, to methods of inhibiting monoamine oxidase and to treating depression, and to pharmaceutical compositions containing the compounds.
本发明涉及由β-
氟亚甲基-5-羟色
氨酸及其衍
生物组成的具有药理活性的新型化合物、抑制单胺氧化酶和治疗抑郁症的方法,以及含有这些化合物的药物组合物。